Doxycycline controlled release - Promius Pharma

Drug Profile

Doxycycline controlled release - Promius Pharma

Alternative Names: DFD 09; Doxycycline modified release - Promius Pharma; Modified release oral tetracycline - Promius Pharma; Zenavod

Latest Information Update: 06 Dec 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Promius Pharma
  • Class Antibacterials; Antimalarials; Small molecules; Tetracyclines
  • Mechanism of Action Protein 30S ribosomal subunit inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preregistration Rosacea

Most Recent Events

  • 30 Nov 2017 Doxycycline controlled release is still tentatively approved in the US
  • 08 Apr 2015 Preregistration for Rosacea in USA (PO) ,
  • 30 May 2013 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top